Process to help personalize treatment for lung cancer patients developed

A process to analyze mutated genes in lung adenocarcinoma to help better select personalized treatment options for patients has been developed by researchers. Adenocarcinoma is the most common type of lung cancer in the United States with approximately 130,000 people diagnosed each year. The study investigated 10 highly mutated and altered genes that contribute to cancer progression, termed oncogenic driver genes, in more than 1,000 lung cancer patients.

Read the whole article on Science Daily

More from Science Daily